Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diabetes: discovery of insulin, genetic, epigenetic and viral infection mediated regulation. | Nucleus (Calcutta) | 2022 | 34629548 | PubTator, text mining | PubMed |
| No significant influence of OCT1 genotypes on the pharmacokinetics of morphine in adult surgical patients. | Basic Clin Pharmacol Toxicol | 2022 | 34599645 | PubTator, text mining | PubMed |
| Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview. | Clin Pharmacokinet | 2022 | 34569009 | PubTator, text mining | PubMed |
| Association of SLC22A1 rs622342 and ATM rs11212617 polymorphisms with metformin efficacy in patients with type 2 diabetes. | Pharmacogenet Genomics | 2022 | 34545025 | PubTator, text mining | PubMed |
| Evaluation of the drug-drug interaction potential of treosulfan using a physiologically-based pharmacokinetic modelling approach. | Br J Clin Pharmacol | 2022 | 34519068 | PubTator, text mining | PubMed |
| Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance. | J Physiol | 2022 | 34505282 | PubTator, text mining | PubMed |
| Genomic editing of metformin efficacy-associated genetic variants in SLC47A1 does not alter SLC47A1 expression. | Hum Mol Genet | 2022 | 34505146 | PubTator, text mining | PubMed |
| Evaluation of the potential drug interactions mediated through P-gp, OCT2, and MATE1/2K with filgotinib in healthy subjects. | Clin Transl Sci | 2022 | 34498807 | PubTator, text mining | PubMed |
| Multi-omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy. | Epilepsia Open | 2022 | 34486831 | PubTator, text mining | PubMed |
| Gutsy science: In vitro systems of the human intestine to model oral drug disposition. | Pharmacol Ther | 2022 | 34478775 | PubTator, text mining | PubMed |
| Computational modeling reveals key molecular properties and dynamic behavior of disruptor of telomeric silencing 1-like (DOT1L) and partnering complexes involved in leukemogenesis. | Proteins | 2022 | 34414607 | PubTator, text mining | PubMed |
| Comparison of clinical pharmacogenetic recommendations across therapeutic areas. | Pharmacogenet Genomics | 2022 | 34412102 | PubTator, text mining | PubMed |
| Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6-Mediated Drug-Drug Interactions on Tramadol and O-Desmethyltramadol Exposures via Allosteric and Competitive Inhibition. | J Clin Pharmacol | 2022 | 34383318 | PubTator, text mining | PubMed |
| Microphysiological systems in absorption, distribution, metabolism, and elimination sciences. | Clin Transl Sci | 2022 | 34378335 | PubTator, text mining | PubMed |
| Metformin Transport Rates Between Plasma and Red Blood Cells in Humans. | Clin Pharmacokinet | 2022 | 34309806 | PubTator, text mining | PubMed |
| Liver-specific decrease in Tff3 gene expression in infant mice perinatally exposed to 2,3,7,8-tetrabromodibenzofuran or 2,3,7,8-tetrachlorodibenzo-p-dioxin. | J Appl Toxicol | 2022 | 34254344 | PubTator, text mining | PubMed |
| Organic Cation Transporters are Involved in Fluoxetine Transport Across the Blood-Brain Barrier In Vivo and In Vitro. | Curr Drug Deliv | 2022 | 34238184 | PubTator, text mining | PubMed |
| Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies. | Gut | 2022 | 34127525 | PubTator, text mining | PubMed |
| Expression and clinical significance of organic cation transporter family in glioblastoma multiforme. | Ir J Med Sci | 2022 | 34080124 | PubTator, text mining | PubMed |
| In Vitro Screening of Three Commercial Cannabis-Based Products on ATP-Binding Cassette and Solute-Carrier Transporter Function. | Cannabis Cannabinoid Res | 2022 | 33998860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=37